Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

CRDLCRDL
Showing 6 of 8 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in CARDIOL THERAPEUTICS INC

TWO SIGMA INVESTMENTS, LP holds 746,937 shares of CRDL (CARDIOL THERAPEUTICS INC), worth $791,753 as of 2026-Q2. The position was increased (+39.8% shares). CRDL represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$791,753

Current Shares

746,937

Total Value Change

+$742,914

Total Shares Change

+722,271

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
746,937
+39.8%
$791,7530.0%$1.06
33
2026-Q1
Increased
534,211
+31.3%
$721,1850.0%$1.01
31
2025-Q4
Increased
406,935
+75.1%
$388,1350.0%$0.97
36
2025-Q3
New
232,345
-
$248,6090.0%$1.14
32
2024-Q4
Exited
0
-100.0%
$00.0%$1.28
0
2024-Q3
New
24,666
-
$48,8390.0%$2.07
28

Other major holders of CRDL: Mirae Asset Global Investments Co., Ltd., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used